7.30% -0.0457

Elevation Oncology Inc (ELEV)

Überblick Nachrichten Preisverlauf Financials Forum Prognose

Finanzdaten der Elevation Oncology Inc-Aktie (ELEV)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2024-03-31	2023-12-31	2023-09-30	2023-06-30	2023-03-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	0.115	-	-	-	-
Operating Expenses	24.20% 9.869	7.946	10.92	9.834	16.75
Benefits Costs and Expenses	10.81	-	-	-	-
Costs And Expenses	10.81	-	-	-	-
Provision For Loan, Lease, And Other Losses	-	-	-	-	-
Operating Income/Loss	24.20% -9.869	-7.946	-10.92	-9.834	-16.75
Net Interest Income/Expense	0.115	-	-	-	-
Interest Income/Expense After Provision For Losses	0.115	-	-	-	-
Income/Loss From Continuing Operations Before Tax	35.56% -10.70	-7.89	-10.62	-10.11	-17.05
Income Tax Expense/Benefit	22.22% 0.011	0.009	0.011	0.005	0.005
Income/Loss From Continuing Operations After Tax	35.55% -10.71	-7.899	-10.64	-10.11	-17.06
Net Income/Loss	35.55% -10.71	-7.899	-10.64	-10.11	-17.06
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	1,586% 47.37	2.81	42.40	27.58	23.62
Diluted Average Shares	1,586% 47.37	2.81	42.40	27.58	23.62
Basic Earnings Per Share	76.92% -0.23	-0.13	-0.25	-0.37	-0.72
Diluted Earnings Per Share	76.92% -0.23	-0.13	-0.25	-0.37	-0.72
Common Stock Dividends	-	-	-	-	-
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

SMMT

$17.87

2.88%

INCY

$68.84

2.65%

MRNA

$39.39

0.43%

UTHR

$359.58

0.16%

BGNE

$176.50

1.02%

BNTX

$113.08

1.56%